Is cannabis still worth investing in during 2025? With increasing legalisation, international expansion, and rising profitability across various sectors, the cannabis industry continues to captivate both retail and institutional investors alike. Yet with so much noise and volatility in the market, understanding where to invest has never been more essential.
That’s where 5starsstocks.com cannabis comes in—a platform dedicated to identifying top-performing cannabis stocks, backed by in-depth financial analysis and sector trends. Whether you’re a seasoned investor or exploring this sector for the first time, having access to curated data and market intelligence can give you a significant edge.
This comprehensive guide explores the cannabis investment landscape through the lens of 5starsstocks.com, covering major U.S. multi-state operators (MSOs), Canadian giants expanding into the American market, ancillary service providers, and the macroeconomic trends shaping cannabis stocks in 2025.
Why Should Cannabis Stocks Still Be on Every Investor’s Radar in 2025?
Cannabis remains one of the fastest-growing industries globally, and 2025 is proving to be another pivotal year. The global market is expected to exceed $67 billion by 2028, and legal reforms continue to reshape how businesses operate and where investors allocate their capital.
In the United States, five additional states are pushing for recreational cannabis legalisation, while four others are set to expand access to medical cannabis. Meanwhile, countries like Germany and Japan are exploring new frameworks, opening the door for international expansion. The UK remains cautiously observant, yet British investors are increasingly looking overseas to capitalise on these developments.
Another key factor fuelling growth is the shifting perception around cannabis. What was once viewed with caution is now recognised for its therapeutic benefits, driving demand for both medical and wellness products. As public and political support increases, the cannabis sector has transformed from a speculative niche into a legitimate long-term investment opportunity.
How Is 5starsstocks.com Supporting Cannabis Investors in Navigating 2025?
In a market as fragmented and dynamic as cannabis, investors need more than just news headlines, they need actionable insights, reliable data, and clear analysis. That’s precisely what 5starsstocks.com cannabis offers.
This platform has carved a niche in sector-specific investment research, with a strong emphasis on cannabis. It helps investors filter out noise and focus on top-tier cannabis stocks that demonstrate profitability, resilience, and long-term growth potential.
Using a rating system based on company fundamentals, financial ratios, and market outlooks, the site ranks cannabis stocks across different segments, U.S. operators, Canadian firms, and ancillary businesses that support the industry infrastructure. Users can also monitor price movements, view earnings reports, and track mergers and acquisitions in real time.
For UK investors who don’t have direct exposure to domestic cannabis equities, this kind of insight becomes especially valuable when looking at foreign-listed cannabis stocks.
Which Multi-State Operators Are Leading the U.S. Cannabis Market in 2025?
The United States continues to be the most mature and profitable cannabis market globally. Among the most influential players in 2025 are Multi-State Operators (MSOs), companies that operate in multiple legal cannabis states, offering both medical and recreational products.
Green Thumb Industries (GTBIF)
Green Thumb Industries has emerged as one of the most stable and promising MSOs. Operating across 15 U.S. states with 91 retail dispensaries, the company has built a robust distribution network that supports consistent revenue growth. In the first quarter of 2025, Green Thumb reported $275.8 million in revenue, an 11% increase year-on-year.
Its gross profit reached $144.9 million, translating to a margin of 52.5%, which reflects the company’s operational efficiency. Even more impressively, the adjusted EBITDA stood at $90.5 million, or 32.8% of revenue—up from 30.7% the previous year. The company holds a strong cash position, with reserves of $223.9 million, making it financially well-prepared for further expansion.
Trulieve Cannabis (TCNNF)
Trulieve continues to dominate in Florida and has gradually expanded its footprint across other states. The company opened new dispensaries in Madison and Panama City, solidifying its presence in high-demand medical cannabis zones.
In Q1 2025, Trulieve posted $298 million in revenue, with a gross profit margin of 58%. Despite reporting a net loss of $23 million, the company generated $139 million from operations and ended the quarter with $327 million in cash. Its strong free cash flow and commitment to expansion reflect a focus on long-term strategic positioning.
Curaleaf Holdings (CURLF)
Curaleaf is currently the most geographically expansive MSO, operating in 17 states with 147 retail outlets and over 900 wholesale accounts. In 2024, the company generated $1.37 billion in revenue, with Q4 revenue alone hitting $345.3 million. The adjusted gross profit margin for Q4 was 48%, reflecting a 1.2% increase from the previous quarter.
Looking forward, Curaleaf is targeting mid-single-digit top-line growth and an adjusted EBITDA margin in the mid-20% range for 2025. Its extensive reach and consistent performance make it a reliable choice for long-term investors.
Are Canadian Cannabis Companies Making Strategic Moves Into the U.S.?
While Canada was the first G7 country to legalise cannabis nationwide, its companies are now looking towards the United States for further growth. Two Canadian firms stand out in 2025 for their aggressive U.S. expansion strategies.
Canopy Growth Corporation (CGC)
Canopy has positioned itself to enter the U.S. market more aggressively through the establishment of Canopy USA, a special purpose vehicle designed to hold its American investments. In 2025, Canopy exercised its rights to acquire both Jetty and Wana, two well-known U.S. cannabis companies.
Rather than absorbing these brands into a single identity, Canopy is focusing on brand autonomy. This strategy could allow each business to scale on its own terms while benefiting from Canopy’s overarching operational and financial support. CEO David Klein has reiterated the company’s focus on long-term, organic growth rather than short-term financial engineering.
Tilray Brands (TLRY)
Tilray has taken a slightly different route by diversifying its investments across the U.S. market, including the acquisition of multiple alcoholic beverage brands. This strategy has made Tilray one of the largest craft brewers in the United States, giving it retail distribution and brand recognition in a parallel but regulated industry.
In 2025, Tilray announced an at-market offering to raise $250 million, earmarked for further acquisitions, including cannabis-related assets. This multi-channel approach is positioning Tilray not only as a cannabis company but as a broader wellness and lifestyle brand.
Which Ancillary Cannabis Stocks Are Poised for Growth in 2025?
Not every profitable cannabis stock is involved in cultivation or retail. Ancillary businesses that supply products, real estate, or services to cannabis operators are often more stable and less exposed to regulatory risk.
GrowGeneration (GRWG)
GrowGeneration is a leading distributor of hydroponic and organic gardening supplies, serving both commercial growers and home cultivation markets. In Q2 2025, the company reported $53.5 million in net sales—an 11.8% quarter-over-quarter increase. Proprietary brands now account for 21.5% of cultivation sales, a significant jump from the previous year.
With a gross profit margin of 26.9% and a newly launched B2B e-commerce platform, GrowGeneration is aiming to have proprietary brands represent 35% of its total sales by the end of the year. The company’s focus on operational efficiency and vertical integration makes it a standout ancillary stock.
Innovative Industrial Properties (IIPR)
IIPR operates as a real estate investment trust (REIT) that leases properties to state-licensed cannabis businesses. The company’s model of sale-leaseback agreements allows cannabis operators to free up capital while securing long-term facility access.
In 2025, IIPR reported consistent rent collection, strong AFFO growth, and a dividend yield of 7%. The REIT trades at just 11.34 times forward AFFO, offering excellent value for income-seeking investors. With $119.5 million earmarked for acquisitions and lease renewals, IIPR remains a solid entry point for indirect cannabis exposure.
What Trends Are Influencing Cannabis Stock Performance in 2025?
Several macroeconomic and policy-driven factors are shaping the cannabis investment landscape this year. One of the most anticipated developments is U.S. federal legalisation. While it has not yet materialised, 2025 may be the turning point.
Legalisation campaigns are gaining traction in Florida, Pennsylvania, and South Dakota, with five states expected to legalise adult-use cannabis and four more advancing medical reforms.
Additionally, mergers and acquisitions continue to reshape the sector. Smaller, cash-strapped companies are becoming acquisition targets for more established players. Strategic deals, like Planet 13’s purchase of a Las Vegas dispensary or SNDL’s acquisition of Indiva, demonstrate how companies are consolidating their market positions through well-timed acquisitions.
Finally, international expansion is also accelerating. Germany’s cannabis reforms, Japan’s evolving perceptions, and Canada’s strong adult-use performance all point to an increasingly interconnected global market.
Which Cannabis Stocks Are Rated 5-Stars by 5starsstocks.com in 2025?
The following table summarises some of the top 5-star cannabis stocks to consider this year:
| Company | Ticker | Segment | Key Strengths |
| Green Thumb Industries | GTBIF | MSO | Strong EBITDA, expanding retail |
| Curaleaf Holdings | CURLF | MSO | Broadest geographic reach |
| Trulieve Cannabis | TCNNF | MSO | High cash flow, Florida dominance |
| Tilray Brands | TLRY | Diversified Cannabis | US expansion, alcohol diversification |
| Innovative Ind. Properties | IIPR | Ancillary Real Estate | Stable REIT model, strong dividends |
These ratings are based on revenue performance, market positioning, growth potential, and risk factors as analysed by 5starsstocks.com.
What Should Investors Consider Before Entering the Cannabis Market?
Investing in cannabis is not without its complexities. The industry is still maturing, and investors must consider several factors:
- Regulatory risk: Constant legal changes require investors to stay informed
- Company fundamentals: Not all cannabis companies are profitable or cash-flow positive
- Geopolitical factors: Global developments can impact market accessibility and investor sentiment
- Diversification: Exposure across multiple verticals—MSOs, ancillary, international—can mitigate risks
Thorough research, supported by tools like 5starsstocks.com, is critical to making well-informed decisions.
What’s the Final Verdict on Cannabis Investing in 2025?
Cannabis investing in 2025 offers both high-growth potential and substantial complexity. With the right strategies, it can be a rewarding sector, especially as federal legalisation in the U.S. moves closer and international markets continue to open.
Platforms like 5starsstocks.com cannabis offer a comprehensive and analytical approach to navigating the cannabis stock universe. Whether you’re looking at MSOs, Canadian players entering the U.S., or low-volatility ancillary providers, the key lies in identifying well-capitalised, efficiently run businesses with clear growth paths.
For UK investors looking to diversify internationally, the cannabis industry represents one of the most promising emerging sectors. Staying informed, diversified, and analytical will be the keys to success.
FAQs About Cannabis Investing and 5starsstocks.com
What is the role of 5starsstocks.com in cannabis investing?
The platform provides curated cannabis stock ratings, performance data, and strategic insights for investors.
Is cannabis investing still high risk in 2025?
While risk has decreased with maturity, regulatory uncertainty still presents challenges.
Can UK investors access cannabis stocks?
Yes, via global brokers offering access to US and Canadian exchanges.
Are REITs like IIPR safer than direct cannabis stocks?
They are generally more stable, offering income through dividends and lower volatility.
What happens if the US legalises cannabis federally?
It could unlock banking access, increase institutional investment, and boost valuations.
Which cannabis stock has the best growth potential?
Green Thumb and Curaleaf are top contenders based on 2025 financials.
How should new investors approach the cannabis sector?
Start with research-focused platforms, assess financials, and diversify across verticals.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or investment recommendations. Always conduct your own research or consult a qualified financial advisor before making any investment decisions, particularly in high-risk sectors such as cannabis.
